Diffuse Intrinsic Pontine Glioma (DIPG)

Oncology·MeSH: Diffuse Intrinsic Pontine Glioma

Prevalence

0.1 / 100K

2 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Compare drugs

Frequently asked questions

How many drugs are in development for Diffuse Intrinsic Pontine Glioma (DIPG)?

BioSniper tracks 2 drugs in development for Diffuse Intrinsic Pontine Glioma (DIPG) across 1 company.

How many clinical trials target Diffuse Intrinsic Pontine Glioma (DIPG)?

There are 1 clinical trial targeting Diffuse Intrinsic Pontine Glioma (DIPG) tracked by BioSniper.

What is the prevalence of Diffuse Intrinsic Pontine Glioma (DIPG)?

The estimated prevalence of Diffuse Intrinsic Pontine Glioma (DIPG) is approximately 0.1 per 100,000 population.

Deep-dive into Diffuse Intrinsic Pontine Glioma (DIPG)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Diffuse Intrinsic Pontine Glioma (DIPG) — Drugs in Development & Clinical Trials | BioSniper